The association of initiating HPV vaccination at ages 9–10 years, 2016-2020

In this video, Adair Minihan, Senior Scientist at the American Cancer Society, summarizes a study on the association between up-to-date human papillomavirus (HPV) vaccination status and starting the vaccine series at younger ages (ages 9 to 10 years) and older ages (at age 11 or later). The study used five years of National Immunization Survey-Teen data between 2016 and 2020 to estimate the up-to-date HPV vaccination prevalence among teens aged 13 to 17 in the two vaccine initiation age groups. Ms. Minihan also examines the sociodemographic differences between older and younger vaccine series initiators. Minihan's is one of the initial articles on initiating HPV vaccination at age nine that will be published over the coming months and featured by the HPV Vaccination Roundtable. The complete collection will be a part of the Special Issues of Human Vaccines and Immunotherapeutics. To read the full publication, visit: https://www.tandfonline.com/journals/... ------------------ ▶︎ Subscribe to HPV Roundtable TV: https://bit.ly/33ymwpu The Human Papillomavirus (HPV) vaccination can help prevent 6 types of cancer. Find accurate, evidence-based information about the HPV vaccine, virus, cancer prevention, and science from National HPV Vaccination Roundtable. Hosted by the American Cancer Society, the National HPV Vaccination Roundtable includes experts from 70+ immunization organizations representing nonprofits, universities, researchers, cancer survivors, and healthcare providers. For more from the National HPV Roundtable: ▶︎ Visit Our Website: https://hpvroundtable.org/ ▶︎ Like Us on Facebook:   / hpvroundtable   ▶︎ Follow Us on Twitter:   / hpvroundtable